Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · IEX Real-Time Price · USD

6.95

-0.05 (-0.71%)

At close: Apr 24, 2024, 4:00 PM

6.91

-0.04 (-0.58%)

After-hours: Apr 24, 2024, 4:25 PM EDT

Pasithea Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	0	0	0.02	0
Cost of Revenue	0	0	0.02	0
Gross Profit	0	0	-0	0
Selling, General & Admin	7.88	9.92	4.51	0.04
Research & Development	8.1	2.67	0	0
Operating Expenses	15.98	12.59	4.51	0.04
Operating Income	-15.98	-12.59	-4.51	-0.04
Interest Expense / Income	0	0	0	0
Other Expense / Income	-0.02	1.35	-2.33	-
Pretax Income	-15.96	-13.94	-2.17	-0.04
Net Income	-15.96	-13.94	-2.17	-0.04
Shares Outstanding (Basic)	1	1	1	0
Shares Outstanding (Diluted)	1	1	1	0
Shares Change	-2.83%	142.65%	41.29%	-
EPS (Basic)	-13.01	-11.03	-4.20	-
EPS (Diluted)	-13.01	-11.03	-4.20	-
Free Cash Flow	-12.74	-12	-3.2	-0.04
Free Cash Flow Per Share	-10.39	-9.51	-6.14	-0.10
Gross Margin	-	-	-14.69%	-
Operating Margin	-	-	-29925.73%	-
Profit Margin	-	-	-14430.49%	-
Free Cash Flow Margin	-	-	-21216.05%	-
EBITDA	-15.31	-13.93	-2.17	-0.04
EBITDA Margin	-	-	-14417.97%	-
Depreciation & Amortization	0.65	0.01	0	0
EBIT	-15.96	-13.94	-2.17	-0.04
EBIT Margin	-	-	-14427.12%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).